Mikania guaco Bonpl. methanol extract showed an interesting activity against Trypanosoma cruzi with an IC 50 of 4 g/mL. Bioassay-guided fractionation of the methanol extract resulted in the isolation of a new sesquiterpene lactone, 2α-acetoxy,15-acetylartemisiifolin (1), which was shown to be active (IC 50 = 25 μM) against the amastigote form of T. cruzi,. The chemical structure of 1 was elucidated using 2-D NMR techniques and mass spectrometry.
Chagas disease (CD), also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi (T. cruzi ). About 6 to 7 million people, mainly in Latin American countries, are estimated to be infected with T. cruzi, where it is mostly vector-borne transmitted to humans by contact with faeces or urine of triatomine bugs, known as 'kissing bugs'. Up to 30% of chronically infected people develop cardiac alterations and up to 10% develop digestive, neurological or mixed alterations which may require specific treatment [1] . In addition to the high cost of treatment for CD with the current drugs, there are many toxic side effects [2] . There is a need for new, safe, effective and cheaper alternative drugs to replace/complement the existing drugs for the treatment of CD.
As part of the activities of the Panama International Cooperative Biodiversity Groups (ICBG) Program [3] [4] [5] aimed at discovering inter alia novel bioactive compounds against different tropical disease targets, an ethyl acetate extract of the young leaves of Mikania guaco showed potent activity against T. cruzi.
The genus Mikania (Asteraceae) is the largest in the Eupatorieae tribe, with more than 430 species, concentrated mainly in tropical regions [6] . Mikania species have been used to treat snakebite [7] , bronchitis [8] , ulcers [9] , and cancer, [10, 11] . M. glomerulata is official in the Brazilian Pharmacopoeia. M. guaco is a thornless, shrubby vine reaching about 2 m in height growing in low and midelevation tropical forests [12] . An extract of M. guaco was found to be effective in mammals in inhibiting the lethal effects of poisonous animals, such as nauyaque snake and rattlesnake, scorpions, spiders and bees [13] .
We found that extracts of M. guaco were active against the amastigote form of T. cruzi and inactive in bioassays designed to detect cytotoxic activity against human tumor cell lines (MCF-7, H-460, and SF-268), Plasmodium falciparum and Leishmania mexicana. M. guaco has not been studied for its biological activity; previous chemical investigation of the plant yielded germacranolides and sesquiterpene lactones [14, 15] .
Bioassay guided fractionation of M. guaco lead to the isolation of a new sesquiterpene lactone 1, which demonstrated activity against T. cruzi with an IC 50 value of 25 M.
Compound 1 was obtained as a semi-solid. Its molecular formula was established as C 19 H 24 O 7 by HRFABMS, which showed a molecular ion peak at m/z 364.15220. The 1 H and 13 C NMR data of 1 (see Experimental Section) in CDCl 3 showed broad unclear signals. Interpretable peaks could be obtained in C 6 D 6 , which showed a singlet at δ 1.55 ppm of one olefinic methyl, signals at δ 6.20, and 6.31 (d, J =3.1 Hz) indicating the presence of an exocyclic methylene group of an ,-unsaturated -lactone; three oxygenated protons at δ 6.27, 4.83, and 4.72; two olefinic protons at δ 4.83 and 4.75, and signals corresponding to two methyls of an acetyl group (δ 1.69 and 1.79). The 13 C NMR spectrum showed signals for 19 carbons, four of which could be assigned to two acetyl groups and the remaining 15 to the main sesquiterpenoid skeleton of 1, which were resolved by DEPT analysis into one methyl, four methylenes (one of them exocyclic), six methines and four quaternary carbons, including the carbonyl of the lactone and three carbons associated with three double bonds. The above data support the presence of a germacranolide skeleton with functionalities similar to those of artmisiifolin [16] , but with an extra acetyloxy and one extra acetate groups. The location of the two acyl groups at C-2 and C-15 were deduced from the chemical shifts of H-2 (6.27) and H-15 (4.68, 4.59) in addition to HMBC observed correlations of H-2/C-3, C-4; H-15/C-4, C-5 and H-3/C-2, C-1, C-4. The proposed structure of 1 was established by comparison of the NMR data with similar structures in the literature. The high field shift of the two acetyl methyl signals in the 1 H NMR spectrum (δ 1.69 and 1.79) was supported by comparison with similar signals recorded in C 6 D 6 [17] . Also, the low shifted H-2 (at δ 6.27) was supported by HMBC correlation with C-3 and C-4, as well as the coupling constant which is typical of 2 orientation (J 23 =11.1 Hz, J 23 = 5.4 Hz) [14] . The chemical shifts of the exomethylene group (H-13) at δ 6.20 and δ 6.31 are in agreement with the more stable C-8 lactonized isomer [18] and their chemical shift is very similar to that of artemisiifolin and other C-8 lactonized isomers reported previously [19, 20] . The relative configuration of 1 was established using 2D-NOESY experiments. With the purpose of checking and corroborating the relative stereochemistry of 1, molecular modeling studies were undertaken (see Figure 1 ). Correlations of H-14/H-8, H-2, H-3/H-2, and H-7/OH-6 were deduced from the observations of this 2D-NOESY experiment. The NOESY correlations of H-14/H-5 indicated a Z configuration of ∆ 4 , while the absence of NOESY correlation and the long range coupling observed between H-15/H-1 indicated an E configuration of ∆ 1 (10) . All of these correlations are in complete agreement with the interprotonic distances measured in model A corresponding to compound 1, whereas the same corresponding distances in model B, the 2-epimer of compound 1, are incompatible with the NOESY effects experimentally observed.
The compound obtained showed some similarity with those isolated from the same species collected from Rio Corinto, Costa Rica [14] , but the NMR demonstrated clear differences, especially for the C-13 and C2 protons. Accordingly, we propose the structure 2α-acetoxy-15-acetylartemisiifolin (1) for this compound (Figure 2 ). Some research groups have put great effort into finding an alternative safe and effective treatment for CD. Up to date there are few bioactive compounds demonstrating significant activity against T. cruzi, including some sesquiterpenes. 15-Acetoxy-8-[(2methylbutyryloxy)]-14-oxo-4,5-cis-acanthospermolide from Acanthospermum hispidum [21] and 8-epixanthatin 1,5-epoxide from Xanthium brasilicum [22] showed interesting activity against T. brucei and T. cruzi. The flora of Panama represents an exciting source to discover new agents to reduce the burden of such a disease. Nevertheless, more studies on the Panamanian flora, as well as derivatization of the isolated compound, in addition to in vivo studies are vital for developing new therapeutic agents for the treatment of CD. 
Intracellular T. cruzi bioassay:
Recombinant Tulahuen clone C4 of T. cruzi that expresses β-galactosidase (β-gal) as a reporter enzyme was used in the assay to determine test samples activity, as previously reported [23] . The method is based on the growth inhibition effect on amastigote, the intracellular form of the parasite, infecting Vero cells. After 3 days of parasite and test samples co-incubation the resulting color from the cleavage of chlorophenol red-β-D-galactoside (CPRG) by β-Gal expressed by the parasite was determined in a Benchmark Plate Reader (BIO-RAD) employing a 570 nm wavelength filter. The antitrypanosmal activity was expressed as IC 50 value, which is a measure of the concentration of the test substance that inhibits 50% of parasite growth in duplicate samples, when compared with an untreated control. Assays were conducted at 37 °C under an atmosphere of 5% CO 2 and 95% air mixture, as reported. 
Extraction and isolation:
Fresh young leaves (600 g) were homogenized with cold methanol for 30 sec in a Waring blender and later with a Polytron homogenizer (Brinkmann Instruments, Inc) for at least 2 min or until the suspension was homogeneous. The mixture was filtered under vacuum through Whatman #4 filter paper, and the marc was then washed with EtOAc. The MeOH and EtOAc extracts were combined and filtered through Whatman #1 filter paper. The extract was concentrated in vacuo at 40 o C and stored at -80 °C until further use (20 g).
Isolation of active constituents of M. guaco:
The crude extract (20 g) was treated by flash column chromatography using a gradient of n-hexane: EtOAc (0% to 100% EtOAc), to yield 10 main fractions. Fraction 6 was shown to retain the activity. Silica gel column chromatography of fraction 6 using 20% EtOAc in n-hexane yielded 1 (20 mg, 0.03 %).
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Molecular modeling studies:
A conformational hybrid search method implemented in Macromodel [24] allowed us to find several conformers for compound 1 and its C-2 epimer. Minimization was performed on each conformation using the MMFF94. The lower energy conformer for every epimer was optimized with GAUSSIAN 09 [25] using DFT [26] at the B3LYP/6-31g(d) level of theory in vacuo. Structural drawings were produced by Spartan08 [27] .
